Big Pharma backs extension for poor countries on trademark rules

In a move that may boost to the pharma industry's reputation in poor countries, the international industry association has backed UK government calls to extend the deadline within which these countries must comply with the intellectual property rules in the World Trade Organization's TRIPS agreement. It is not yet clear what the new deadline will be.